SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Summers C., Rankin S.M., Condliffe A.M., Singh N., Peters A.M., Chilvers E.R. ( 2010) Neutrophil kinetics in health and disease. Trends Immunol 31: 31824.
  • 2
    Maghazachi A.A. ( 2010) Role of chemokines in the biology of natural killer cells. Curr Top Microbiol Immunol 341: 3758.
  • 3
    McNeill E., Channon K.M., Greaves D.R. ( 2010) Inflammatory cell recruitment in cardiovascular disease: murine models and potential clinical applications. Clin Sci (Lond) 118: 64155.
  • 4
    Kittan N.A., Hildebrandt G.C. ( 2010) The chemokine system: a possible therapeutic target in acute graft versus host disease. Curr Top Microbiol Immunol 341: 97120.
  • 5
    Shen Y., Xu W., Chu Y.W., Wang Y., Liu Q.S., Xiong S.D. ( 2004) Coxsackievirus group B type 3 infection upregulates expression of monocyte chemoattractant protein1 in cardiac myocytes, which leads to enhanced migration of mononuclear cells in viral myocarditis. J Virol 78. Vol. 12, pp. 54856.
  • 6
    Shen Y., Kan Q.C., Xu W., Chu Y.W., Xiong S.D. ( 2009) Coxsackievirus B3 infection induced viral myocarditis by regulating the expression pattern of chemokines in cardiac myocytes. Iran J Allergy Asthma Immunol 8: 19.
  • 7
    Melgarejo E., Medina M.A., Sánchez-Jiménez F., Urdiales J.L. ( 2009) Monocyte chemoattractant protein-1: a key mediator in inflammatory processes. Int J Biochem Cell Biol 41: 9981001.
  • 8
    Koga M., Kai H., Egami K., Murohara T., Ikeda A., Yasuoka S., Egashira K., Matsuishi T., Kai M., Kataoka Y., Kuwano M., Imaizumi T. ( 2008) Mutant MCP-1 therapy inhibits tumor angiogenesis and growth of malignant melanoma in mice. Biochem Biophys Res Commun 365: 27984.
  • 9
    Schmidtke M., Hammerschmidt E., Schüler S., Zell R., Birch-Hirschfeld E., Makarov V.A., Riabova O.B., Wutzler P. ( 2005) Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment. J Antimicrob Chemother 56: 64856.
  • 10
    LaBarre D.D., Lowy R.J. ( 2001) Improvements in methods for calculating virus titer estimates from TCID50 and plaque assays. J Virol Methods 96: 10726.
  • 11
    Lim B.K., Choe S.C., Shin J.O., Ho S.H., Kim J.M., Yu S.S., Kim S., Jeon E.S. ( 2002) Local expression of interleukin-1 receptor antagonist by plasmid DNA improves mortality and decreases myocardial inflammation in experimental coxsackieviral myocarditis. Circulation 105: 127881.
  • 12
    Henke A., Huber S.A., Stelzner A., Whitton J.L. ( 1995) The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. J Virol 69: 67208.
  • 13
    Kishimoto C., Kawamata H., Sakai S., Shinohara H., Ochiai H. ( 2001) Enhanced production of macrophage inflammatory protein 2 (MIP-2) by in vitro and in vivo infections with encephalomyocarditis virus and modulation of myocarditis with an antibody against MIP-2. J Virol 75: 1294300.
  • 14
    Deshmane S.L., Kremlev S., Amini S., Sawaya B.E. ( 2009) Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 29: 31326.
  • 15
    Lovett D.H., Mahimkar R., Raffai R.L., Cape L., Zhu B.Q., Jin Z.Q., Baker A.J., Karliner J.S. ( 2013) N-terminal truncated intracellular matrix metalloproteinase-2 induces cardiomyocyte hypertrophy, inflammation and systolic heart failure. PLoS One 8: 68154.
  • 16
    Cai K., Qi D., Hou X., Wang O., Chen J., Deng B., Qian L., Liu X., Le Y. ( 2011) MCP-1 upregulates amylin expression in murine pancreatic β Cells through ERK/JNK-AP1 and NF-κB related signaling pathways independent of CCR2. PLoS ONE 6: e19559.
  • 17
    Kolattukudy P.E., Niu J. ( 2012) Inflammation, ER stress, autophagy and MCP-1/CCR2 pathway. Circ Res 110: 17489.
  • 18
    Struthers M., Pasternak A. ( 2010) CCR2 antagonists. Curr Top Med Chem 10: 12789.
  • 19
    Kito K., Morishita K., Nishida K. ( 2001) MCP-1 receptor binding affinity is up-regulated by pre-stimulation with MCP-1 in an actin polymerization-dependent manner. J Leukoc Biol 69: 66674.
  • 20
    Egashira K. ( 2003) Molecular mechanisms mediating inflammation in vascular disease: special reference to monocyte chemoattractant protein-1. Hypertension 41: 83441.
  • 21
    Seet B.T., Singh R., Paavola C., Lau E.K., Handel T.M., McFadden G. ( 2001) Molecular determinants for CC-chemokine recognition by a poxvirus CC-chemokine inhibitor. Proc Natl Acad Sci USA 98: 900813.
  • 22
    Steitz S.A., Hasegawa K., Chiang S.L., Cobb R.R., Castro M.A., Lobl T.J., Yamada M., Lazarides E., Cardarelli P.M. ( 1998) Mapping of MCP-1 functional domains by peptide analysis and site-directed mutagenesis. FEBS Lett 430: 15864.
  • 23
    Mizoue L.S., Sullivan S.K., King D.S., Kledal T.N., Schwartz T.W., Bacon K.B., Handel T.M. ( 2001) Molecular determinants of receptor binding and signaling by the CX3C chemokine Fractalkine. J Biol Chem 276: 3390614.
  • 24
    Shao W., Fernandez E., Sachpatzidis A., Wilken J., Thompson D.A., Schweitzer B.I., Lolis E. ( 2001) CCR2 and CCR5 receptor-binding properties of herpesvirus-8 vMIP-II based on sequence analysis and its solution structure. Eur J Biochem 268: 294859.
  • 25
    Que B.G., Wise G.E. ( 1998) Tooth eruption molecules enhance MCP-1gene expression in the dental follicle of the rat. Dev Dyn 212: 34651.
  • 26
    Gong J.H., Ian C.L. ( 1995) Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues. J Exp Med 181: 63140.
  • 27
    He M., Liang X., He L., Wen W., Zhao S., Wen L., Liu Y., Shyy J.Y., Yuan Z. ( 2013) Endothelial dysfunction in rheumatoid arthritis: the role of monocyte chemotactic protein-1-induced protein. Arterioscler Thromb Vasc Biol 33: 138491.
  • 28
    Klinghammer L., Urschel K., Cicha I., Lewczuk P., Raaz-Schrauder D., Achenbach S., Garlichs C.D. ( 2013) Impact of telmisartan on the inflammatory state in patients with coronary atherosclerosis—Influence on IP-10, TNF-alpha and MCP-1. Cytokine 62: 2906.
  • 29
    Walczak A., Przybyłowska K., Sygut A., Dziki L., Chojnacki C., Chojnacki J., Dziki A., Majsterek I. ( 2012) The -2518 A/G MCP-1 polymorphism as a risk factor of inflammatory bowel disease. Polski Przeglad Chirurgiczny 84: 23841.
  • 30
    Camargo P.R., Okay T.S., Yamamoto L., Del Negro G.M., Lopes A.A. ( 2011) Myocarditis in children and detection of viruses in myocardial tissue: implications for immunosuppressive therapy. Int J Cardiol 148: 2048.